Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Flurandrenolide topical preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fludroxycortide |
Inferred relationship |
Some |
|
Flurandrenolone adverse reaction (disorder) |
Causative agent (attribute) |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Allergy to fludroxycortide |
Causative agent (attribute) |
False |
Fludroxycortide |
Inferred relationship |
Some |
|
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fludroxycortide |
Inferred relationship |
Some |
|
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fludroxycortide |
Inferred relationship |
Some |
|
Flurandrenolide 4mcg tape |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fludroxycortide |
Inferred relationship |
Some |
|
Fludroxycortide 250 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fludroxycortide |
Inferred relationship |
Some |
|
Fludroxycortide 500 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fludroxycortide |
Inferred relationship |
Some |
|
Fludroxycortide 250 microgram/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fludroxycortide |
Inferred relationship |
Some |
|
Product containing precisely fludroxycortide 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fludroxycortide |
Inferred relationship |
Some |
|
Flurandrenolide 4mcg/sq/cm tape |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fludroxycortide |
Inferred relationship |
Some |
|
Fludroxycortide 500 microgram/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fludroxycortide |
Inferred relationship |
Some |
|
Product containing fludroxycortide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Allergy to fludroxycortide |
Causative agent (attribute) |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Allergy to fludroxycortide |
Causative agent (attribute) |
False |
Fludroxycortide |
Inferred relationship |
Some |
2 |
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Product containing fludroxycortide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Product containing only fludroxycortide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Fludroxycortide only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Fludroxycortide 500 microgram/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Fludroxycortide 500 microgram/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Fludroxycortide 250 microgram/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Fludroxycortide 250 microgram/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Fludroxycortide 500 microgram/mL cutaneous lotion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Fludroxycortide 500 microgram/mL cutaneous lotion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Product containing precisely fludroxycortide 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Product containing precisely fludroxycortide 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Fludroxycortide 250 microgram/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |
Fludroxycortide 250 microgram/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fludroxycortide |
Inferred relationship |
Some |
1 |